LPL Financial
KURA icon

LPL Financial’s Kura Oncology KURA Stock Holding History

LPL Financial’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
27,790
+12,994
+88% +$123K ﹤0.01% 5438
2026
Q1 		$120K Buy
14,796
+4,691
+46% +$40.3K ﹤0.01% 5636
2025
Q4 		$105K Buy
+10,105
New +$106K ﹤0.01% 5584

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

LPL Financial's KURA Position: Q2 2026 in Review

LPL Financial increased its Kura Oncology (KURA) stake by 88% in Q2 2026, buying an estimated $123K and bringing the position to 27,790 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #5438.

LPL Financial first reported a position in KURA in Q4 2025 and has held it in 3 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • LPL Financial held 27,790 shares of Kura Oncology worth $305K as of Q2 2026.
  • LPL Financial bought 12,994 Kura Oncology shares in Q2 2026, an estimated $123K.
  • Kura Oncology made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5438 holding.
  • LPL Financial first reported a position in Kura Oncology in Q4 2025 and has held it in 3 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.